121 related articles for article (PubMed ID: 8836814)
1. Inducing properties of rifampicin and rifabutin for selected enzyme activities of the cytochrome P-450 and UDP-glucuronosyltransferase superfamilies in female rat liver.
Oesch F; Arand M; Benedetti MS; Castelli MG; Dostert P
J Antimicrob Chemother; 1996 Jun; 37(6):1111-9. PubMed ID: 8836814
[TBL] [Abstract][Full Text] [Related]
2. Primary human hepatocytes as a tool for the evaluation of structure-activity relationship in cytochrome P450 induction potential of xenobiotics: evaluation of rifampin, rifapentine and rifabutin.
Li AP; Reith MK; Rasmussen A; Gorski JC; Hall SD; Xu L; Kaminski DL; Cheng LK
Chem Biol Interact; 1997 Nov; 107(1-2):17-30. PubMed ID: 9402947
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of rifabutin and rifampicin on cytochromes P450 and UDP-glucuronosyl-transferases expression in fresh and cryopreserved human hepatocytes.
Reinach B; de Sousa G; Dostert P; Ings R; Gugenheim J; Rahmani R
Chem Biol Interact; 1999 Jun; 121(1):37-48. PubMed ID: 10418969
[TBL] [Abstract][Full Text] [Related]
4. Induction and autoinduction properties of rifamycin derivatives: a review of animal and human studies.
Strolin Benedetti M; Dostert P
Environ Health Perspect; 1994 Nov; 102 Suppl 9(Suppl 9):101-5. PubMed ID: 7698069
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory Effects of Selected Antituberculosis Drugs on Common Human Hepatic Cytochrome P450 and UDP-glucuronosyltransferase Enzymes.
Cao L; Greenblatt DJ; Kwara A
Drug Metab Dispos; 2017 Sep; 45(9):1035-1043. PubMed ID: 28663285
[TBL] [Abstract][Full Text] [Related]
6. CYP3A inductive potential of the rifamycins, rifabutin and rifampin, in the rabbit.
Weber A; Kaplan M; Chughtai SA; Cohn LA; Smith AL; Unadkat JD
Biopharm Drug Dispos; 2001 May; 22(4):157-68. PubMed ID: 11745918
[TBL] [Abstract][Full Text] [Related]
7. Effect of a new rifamycin derivative, rifalazil, on liver microsomal enzyme induction in rat and dog.
Mae T; Hosoe K; Yamamoto T; Hidaka T; Ohashi T; Kleeman JM; Adams PE
Xenobiotica; 1998 Aug; 28(8):759-66. PubMed ID: 9741954
[TBL] [Abstract][Full Text] [Related]
8. Drug metabolism in hepatocyte sandwich cultures of rats and humans.
Kern A; Bader A; Pichlmayr R; Sewing KF
Biochem Pharmacol; 1997 Oct; 54(7):761-72. PubMed ID: 9353130
[TBL] [Abstract][Full Text] [Related]
9. Inducibility of ethoxyresorufin deethylase and UDP-glucuronosyltransferase activities in two human hepatocarcinoma cell lines KYN-2 and Mz-Hep-1.
Abid A; Sabolovic N; Magdalou J
Cell Biol Toxicol; 1996 Apr; 12(2):115-23. PubMed ID: 8738480
[TBL] [Abstract][Full Text] [Related]
10. The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive.
Barditch-Crovo P; Trapnell CB; Ette E; Zacur HA; Coresh J; Rocco LE; Hendrix CW; Flexner C
Clin Pharmacol Ther; 1999 Apr; 65(4):428-38. PubMed ID: 10223781
[TBL] [Abstract][Full Text] [Related]
11. Expression of hepatic cytochrome P450s and UDP-glucuronosyltransferases in PXR and CAR double humanized mice treated with rifampicin.
Lee SY; Lee JY; Kim YM; Kim SK; Oh SJ
Toxicol Lett; 2015 Jun; 235(2):107-15. PubMed ID: 25835148
[TBL] [Abstract][Full Text] [Related]
12. In-vitro activity of rifabutin against rifampicin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations.
Cavusoglu C; Karaca-Derici Y; Bilgic A
Clin Microbiol Infect; 2004 Jul; 10(7):662-5. PubMed ID: 15214882
[TBL] [Abstract][Full Text] [Related]
13. Strychnine and brucine as the potent inducers of drug metabolizing enzymes in rat liver: different profiles from phenobarbital on the induction of cytochrome P450 and UDP-glucuronosyltransferase.
Fujisaki H; Mise M; Ishii Y; Yamada H; Oguri K
J Pharmacol Exp Ther; 1994 Feb; 268(2):1024-31. PubMed ID: 7906730
[TBL] [Abstract][Full Text] [Related]
14. Induction of hepatic and presystemic metabolism of antipyrine in the mice: rifampicin versus rifabutin.
Liu XG; Narang PK; Li RC
Eur J Drug Metab Pharmacokinet; 2001; 26(4):209-13. PubMed ID: 11808861
[TBL] [Abstract][Full Text] [Related]
15. Relationship between antimycobacterial activities of rifampicin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis.
Yang B; Koga H; Ohno H; Ogawa K; Fukuda M; Hirakata Y; Maesaki S; Tomono K; Tashiro T; Kohno S
J Antimicrob Chemother; 1998 Nov; 42(5):621-8. PubMed ID: 9848446
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive in vitro analysis evaluating the variable drug-drug interaction risk of rifampicin compared to rifabutin.
Nilles J; Weiss J; Sauter M; Haefeli WE; Ruez S; Theile D
Arch Toxicol; 2023 Aug; 97(8):2219-2230. PubMed ID: 37285043
[TBL] [Abstract][Full Text] [Related]
17. Effects of the agrochemicals butachlor, pretilachlor and isoprothiolane on rat liver xenobiotic-metabolizing enzymes.
Ishizuka M; Iwata H; Kazusaka A; Hatakeyama S; Fujita S
Xenobiotica; 1998 Nov; 28(11):1029-39. PubMed ID: 9879635
[TBL] [Abstract][Full Text] [Related]
18. In vivo induction of human cytochrome P450 3A4 by rifabutin in chimeric mice with humanized liver.
Katoh M; Watanabe M; Tabata T; Sato Y; Nakajima M; Nishimura M; Naito S; Tateno C; Iwasaki K; Yoshizato K; Yokoi T
Xenobiotica; 2005 Sep; 35(9):863-75. PubMed ID: 16308281
[TBL] [Abstract][Full Text] [Related]
19. Management of Drug Interactions with Inducers: Onset and Disappearance of Induction on Cytochrome P450 3A4 and Uridine Diphosphate Glucuronosyltransferase 1A1 Substrates.
Bettonte S; Berton M; Stader F; Battegay M; Marzolini C
Eur J Drug Metab Pharmacokinet; 2023 Jul; 48(4):353-362. PubMed ID: 37278880
[TBL] [Abstract][Full Text] [Related]
20. Induction of rat liver bilirubin-conjugating enzymes and glutathione S-transferase by rifampicin.
Adachi Y; Nanno T; Yamashita M; Ueshima S; Yamamoto T
Gastroenterol Jpn; 1985 Apr; 20(2):104-10. PubMed ID: 3161772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
